fbpx

Patients, visitors, staff and healthcare providers can find the latest COVID-19 updates here.

Research

About

Research is a fundamental part of what we do at Hamilton Health Sciences. In partnership with McMaster University, we have a decades-long track record of making discoveries that change how healthcare is delivered around the world.

Our culture of exploration and innovation has attracted top research talent from across Canada and beyond, and we’re consistently ranked among the country’s top research hospitals.

Learn more about research at Hamilton Health Sciences below.

Research Leadership Team

Dr. Salim Yusuf
Dr. Salim Yusuf
Chief Scientist

Dr. Salim Yusuf is the Founder and Executive Director of the Population Health Research Institute (PHRI), a joint member of the Department of Clinical Epidemiology & Biostatistics, a cardiologist at the Hamilton General Hospital, and a professor in the Department of Medicine at McMaster University.

Dr. Yusuf’s research interests include the prevention and treatment of cardiovascular disease and societal, biologic and, genetic determinants of population health in developing populations. His team's studies are conducted in 86 countries in all of the inhabited continents of the world.

Sandra Carroll headshot
Dr. Sandra Carroll
Director, Clinical Health Professional Research

Dr. Carroll is the Vice-Dean, Faculty of Health Sciences and Executive Director of the School of Nursing at McMaster University. She is also an Associate Scientist at the Population Health Research Institute of Hamilton Health Sciences and McMaster University. Dr. Carroll’s research interests include patients’ decision-making, decision support in the context of implantable defibrillators, patient preferences for cardiovascular treatments, and patient reported outcomes in arrhythmia care. Dr. Carroll has received operating funds from the Canadian Institutes of Health Research and the Heart & Stroke Foundation.

Dr. Ted Scott
Vice President, Research & Chief Innovation Officer

Dr. Scott brings resources, partnerships and thought leadership to healthcare innovation. He is Chair of the Synapse Life Sciences Consortium in Hamilton, and was previously Chief Innovation Officer and Dean of Applied Research at Mohawk College, where he studied Radiography and Sonography. Ted is an expert digital health strategist and has a wealth of experience in industry relations and procurement, as well as innovation policy. He returned to HHS where he started his career as a sonographer after working at The Hospital for Sick Children and Huntsville District Memorial Hospital. Ted is a lifelong learner who earned his Masters of Applied Science in Medical Ultrasound and his PhD in Diagnostic Imaging from Charles Sturt University of Australia.

Dr. Salim Yusuf is the Founder and Executive Director of the Population Health Research Institute (PHRI), a joint member of the Department of Clinical Epidemiology & Biostatistics, a cardiologist at the Hamilton General Hospital, and a professor in the Department of Medicine at McMaster University.

Dr. Yusuf’s research interests include the prevention and treatment of cardiovascular disease and societal, biologic and, genetic determinants of population health in developing populations. His team's studies are conducted in 86 countries in all of the inhabited continents of the world.

Dr. Carroll is the Vice-Dean, Faculty of Health Sciences and Executive Director of the School of Nursing at McMaster University. She is also an Associate Scientist at the Population Health Research Institute of Hamilton Health Sciences and McMaster University. Dr. Carroll’s research interests include patients’ decision-making, decision support in the context of implantable defibrillators, patient preferences for cardiovascular treatments, and patient reported outcomes in arrhythmia care. Dr. Carroll has received operating funds from the Canadian Institutes of Health Research and the Heart & Stroke Foundation.

Dr. Scott brings resources, partnerships and thought leadership to healthcare innovation. He is Chair of the Synapse Life Sciences Consortium in Hamilton, and was previously Chief Innovation Officer and Dean of Applied Research at Mohawk College, where he studied Radiography and Sonography. Ted is an expert digital health strategist and has a wealth of experience in industry relations and procurement, as well as innovation policy. He returned to HHS where he started his career as a sonographer after working at The Hospital for Sick Children and Huntsville District Memorial Hospital. Ted is a lifelong learner who earned his Masters of Applied Science in Medical Ultrasound and his PhD in Diagnostic Imaging from Charles Sturt University of Australia.

Reports & Publications

Our Institutes

Research at Hamilton Health Sciences happens across our many programs and services, and on varying scales. Much of our research is led by our five specialized research institutes. Together, they conduct research that advances patient care by bringing evidence into practice through translation and application in to real-world environments.

At Hamilton Health Sciences, our research happens in real-time at the bedsides of our patients and across our many programs and services. That research is supported by world-class infrastructure, including Canada’s largest biobank and a family of research institutes, each with expertise in a unique area which, collectively, cover the spectrum of health and disease. All of our research institutes are operated in partnership with McMaster University. Click on the images below to learn more.

Learn more about Hamilton Health Sciences’ research institutes below.

Population Health Research Institute

A world leader in large clinical trials and population studies, Population Health Research Institute (PHRI) is Canada’s premier cardiovascular research institute. World-class researchers conduct some of the largest studies in the world, spanning all frontiers of the globe and covering a broad spectrum of health-related issues. PHRI’s population science focus examines biological and genetic determinants, as well as social, environmental and policy factors, with an emphasis on risk factors and the prevention of heart attacks, stroke, diabetes, kidney disease and cognitive decline. PHRI has conducted more than 80 global trials and epidemiological studies in more than 1,500 centres, in 86 countries, in all inhabited continents.

Visit the PHRI website to learn more.

Escarpment Cancer Research Institute

The Escarpment Cancer Research Institute (ECRI) is focused on improving care for cancer patients by focusing on three thematic areas: clinical trials, quality health care and knowledge translation research, and transitional (bench-to-bedside) research. ECRI brings together successful, well-established teams with newly formed cancer research groups in order to embrace and create new opportunities for synergies in research.

Visit the ECRI website to learn more.

Thrombosis and Atherosclerosis Research Institute

The primary focus of the Thrombosis & Atherosclerosis Research Institute (TaARI) is research excellence in thrombosis and atherosclerosis. TaARI’s core research programs include the Experimental Thrombosis and Atherosclerosis Program, the Clinical Thromboembolism Program, the Biometrics Group, and the Comparative Medicine Program which focuses on the translation of basic research findings into clinically relevant models prior to evaluation in humans.

Visit the TaARI website to learn more.

Offord Centre for Child Studies

Research conducted at the Offord Centre has had an important impact in Ontario, in Canada, and internationally. It is commonly stated that one in five children in Canada have a mental health challenge. That statistic comes from the Offord Centre’s 1983 landmark study, The Ontario Child Health Study, one of the most important population-based studies on children’s mental health conducted anywhere in the last 30 years.

Visit the Offord Centre website to learn more.

GERAS Centre for Aging Research

The GERAS Centre is committed to educating and empowering seniors to regain and retain independence and to manage their health through active participation in their care. These new models of care engage family members and build capacity for support within the community. The experts at St. Peter’s Hospital are also dedicated to advancing healthcare education for the present and next generation of healthcare professionals. Through innovative research the GERAS Centre aims to close the gap between knowing and doing to contribute to improved quality of life for seniors.

Visit the GERAS Centre website to learn more.

Clinical Research Library and Biobank

The Clinical Research Laboratory and Biobank (CRLB) is a state-of-the-art research facility which provides comprehensive Central Laboratory services to support global clinical studies and innovative research. The facility has the capacity to accommodate 100 large storage tanks, each holding approximately 80,000 vials. Samples in the Biobank are linked to relevant clinical information relating to diabetes, obesity, cardiovascular disease, hypertension, stroke, kidney disease, fractures and cancer. It is the largest research biobank in Canada, with several million samples from around the world which support on-going research at Hamilton Health Sciences.

Visit the CRLB website to learn more.

Our Expertise

Hamilton Health Sciences’ Research Administration team is available to support the needs of the hospital’s research community by offering expertise in the following areas:

  • clinical contracts and agreements
  • clinical research ethics
  • development and relations
  • financial services
  • infrastructure support/resources
  • internal funding opportunities

Collaboration

We welcome opportunities to collaborate with fellow healthcare institutions and providers, research centres, and other industries on comprehensive research studies and trials that align to Hamilton Health Sciences’ research programs and vision.

Find more information about how to collaborate with us on research initiatives below.

Youth Outreach Programs

Hamilton Health Sciences has two highly sought-after Youth Outreach Programs designed to mentor the next generation.

Discovery Days In Health Sciences: A one-day symposium for Ontario high school students in grades 10-12 who are considering a career in Health Sciences.

High School Research Bursary: Designed for senior high school students interested in pursuing, or accepted into, university or college level post-secondary studies in Health or Life Sciences.

Capabilities

Hamilton Health Sciences has multiple clinical sites and a rich, collaborative research network. This has helped to accelerate the knowledge transfer process and ensure best proven practices for healthcare delivery.

Covering a broad spectrum of health research, HHS investigators explore basic laboratory, clinical and epidemiological research. Strict guidelines and policies combined with a sophisticated infrastructure support system ensure the highest level of data integrity, adherence to national and international regulations, and timely reports. Our teams provide start to completion expertise, including:

  • Conceptual development & protocol
  • Study design and set-up, data management, statistical analysis
  • Study initiation, site selection, recruitment, regulatory approval
  • Study maintenance: ongoing monitoring, study close-out, data analysis, central laboratory analysis, presentation of final results
  • Publication and dissemination of study results
  • Regulatory submissions, clinical trial reports

Contract Policies

Hamilton Health Sciences protects you and your patients with the following:

Legally-binding agreements

Confidentiality agreements, clinical trial agreements, site agreements, amendments, grant agreements, memorandum of understanding, data sharing agreements, material transfer agreements.

Internal Policies

The research contracts team ensures our internal policies on research, publication, intellectual property, insurance, etc. are followed.

CAHO – The Council of Academic Hospitals of Ontario

We base our clinical trial agreements on the CAHO Statement of Principles. In fact, we were on the CAHO Steering Committee that developed these principles.

CAHO Harmonization of Clinical Study Agreements Initiative

In an effort to reduce timelines and promote transparency in contract negotiation, HHS has adopted the document developed through an initiative of Council of Academic Hospitals of Ontario (CAHO) and entitled “Statement of Principles to be Considered when Negotiating a Clinical Studies Agreement” which can be accessed on the CAHO website, or is available for download here. HHS encourages companies to review and incorporate these principles into its clinical study agreement templates prior to entering into negotiations with us. If any of the items in the principles document are issues of concern, please do not hesitate to contact the Research Contracts Team to discuss them.

Contact Us

To learn more about collaborative opportunities with Hamilton Health Sciences Research, contact us:

293 Wellington St. N., Suite 120
Hamilton, ON

Innovation

The Research and Innovation Team welcomes opportunities to collaborate with fellow healthcare institutions and providers, research centres, and industry partners on various research and innovation projects that align to Hamilton Health Sciences’ research programs and vision. We are proud to have an environment that encourages and cultivates innovation through our initiatives and collaboration. Our team is equipped to offer additional services, support, and can help to identify different opportunities for our academic, public and private sector partners on an ad-hoc basis.

Hamilton Health Sciences also provides numerous resources to external research, public and private sector partners in order to assist their research translation and commercialization needs:

  • Identify and facilitate opportunities for collaboration with our rich and diverse research areas and investigators at HHS
  • Connections to HHS investigators to initiate basic research, pilot studies, feasibility, validation and clinical trials
  • Hands-on support with commercialization activities, grant applications, letters of support, contracts, agreements and research compliance.
  • Dedicated expertise to identify appropriate funding opportunities around R&D, knowledge translation, technology transfer, innovation, executive support, market access, etc.

Contact Us

To learn more about collaborative opportunities with Hamilton Health Sciences Research and Innovation, contact us:

researchinnovation@hhsc.ca
293 Wellington St N, Suite 132
Hamilton, Ontario

Internal Funding

**These funding opportunities are limited to Hamilton Health Sciences Researchers which includes McMaster University faculty members who must have a formal cross appointment with Hamilton Health Sciences**

Hamilton Health Sciences (HHS) takes a strategic approach in developing internal funding programs for its research community, including front-line staff. HHS invests approximately $1.6 million dollars annually to provide operating grants, career awards, and travel awards, as well as mentorship opportunities through two province-wide youth outreach programs. Funding and mentoring programs are awarded through peer-review competitions designed to support every career stage, from senior investigators with established, large-scale research studies, to early-career investigators initiating their first research study.

HHS Strategy Resource Documents:

HHS Corporate Strategic Plan
HHS Digital Health Plan
HHS People Plan
Planning Our Healthy Future

New Investigator Fund (NIF)

Hamilton Health Sciences’ commitment to “first stage” research led to the creation of the New Investigator Fund (NIF). The NIF provides a unique opportunity to foster and support a culture of inquiry for novice investigators under the mentorship of senior researchers. The NIF provides project funding to front-line staff ( who are healthcare professionals and medical staff) towards research initiatives directly relevant to the Clinical Mission, Strategy–Pillars and Strategic Directions of Hamilton Health Sciences. Priority areas for funding include the following:

  • Consistent with, and likely to enhance, the main clinical programs/priorities at HHS
  • Enhances research enterprise/profile at HHS
  • Multidisciplinary and collaborative (involving more than one department or program or healthcare discipline and institution)
  • Builds on existing research strengths
  • Advances and creates new knowledge that informs patient care by bringing evidence into practice through translation and application
  • Conduct of pilot or feasibility studies which could facilitate obtaining funding for full scale studies through independent peer review or other mechanisms.

​For more information contact Donna Catherwood, catherwood@hhsc.ca

Important Dates

Spring deadline: March 31
Fall deadline: October 1

Important Forms

NIF Application Form
NIF Budget Form
NIF Guidelines for Application
NIF Lay Summary Form 
NIF Progress & Completion Form

Submit to NIF@hhsc.ca

Past Recipients 

2019 NIF Award Recipients

Early Research Career Awards (ECA)

“Dr. David Sackett’s legacy to carry forward for years to come through naming one of Hamilton Health Sciences Research Early Career Awards in his honour – recognizing his lifetime contribution and accomplishments in advancing medical sciences and in mentoring several generations of researchers.”

The Hamilton Health Sciences Research Early Career Awards (ECA) are research personnel stipends awarded annually. These Early Career Awards are to be used to help the applicant pursue research in their specialty area through either purchasing a portion of time for the applicant’s salary OR a portion of time for salaries of research personnel who are supervised by the applicant.

​For more information contact Donna Catherwood, catherwood@hhsc.ca

Important Dates

Submission deadline: November 15

Important Forms

ECA Application Form
ECA Guidelines for Application
ECA Renewal Report Form
ECA Year 3 Completion Report

Submit to: careerawards@hhsc.ca

Past Recipients 

2019 ECA Award Recipients
2020 ECA Award Recipients

Health Professional Investigator Operating Grant (HPI)

Funding Available: up to $15,000 per grant: a total of three grants available for a one-year term.

The Health Professional Investigator (HPI) Operating Grant provides project funding to principal investigators (PI) who are HHS-employed healthcare professionals. Inter-professional teams, which include physicians, are encouraged, but physicians are not eligible to apply as lead PI for this grant. The HPI Operating Grant is for research initiatives directly relevant to the clinical mission and priorities/strategic plan of HHS (Patients, People, Sustainability, Innovation and Learning). The grant objective is to provide support for pilot studies or research projects that have the potential to lead to larger projects and the possibility of external funding. The HPI Operating Grant offers an opportunity to foster and support a culture of inquiry for novice to novice to mid-career investigators under the mentorship of experienced researchers. Priority areas for funding include the following:

This funding program is led by Dr. Sandra Carroll, Director, Clinical Health Professional Research, carroll@mcmaster.ca. Interested candidates are recommended to contact Dr. Carroll or Daniela Bianco biancdan@hhsc.ca in advance of their submission.

For more information and/or assistance, please contact Donna Catherwood, catherwood@hhsc.ca

Important Dates

Spring submission deadline: May 1
Fall submission deadline: October 31

Important Forms

HPI Application Form
HPI Budget Form
HPI Completion Report
HPI Guidelines for Application
HPI Progress Report

Submit to: HPI@hhsc.ca

Past Recipients 

2019 HPI Award Recipients

Clinical Health Professional Personnel Award (CHPA)

PLEASE NOTE: THERE WILL BE NO 2020 COMPETITION OFFERED

The Hamilton Health Sciences Clinical Health Professional Research Personnel Award is a one-time personnel stipend award. The award is to be used to help a suitably qualified non-physician health professional who has demonstrated an aptitude for research to pursue research in their discipline, by providing protected time through financial support for a portion of the applicant’s salary.

General Information

  • One new award will be offered in 2020 for the duration of one year. It is expected that the award will begin on July 1, 2020.
  • The value of the award will be up to $50,000 for the purpose of supporting up to 0.40 FTE protected time to be dedicated to research.
  • Funding may be extended for a second year, contingent upon the recipient’s demonstrated progress, productivity, and availability of funds. Refer to CHPA guidelines for requirements and process.

This funding program is led by Dr. Sandra Carroll, Director, Clinical Health Professional Research, carroll@mcmaster.ca. Interested candidates are recommended to contact Dr. Carroll or Daniela Bianco biancdan@hhsc.ca in advance of their submission.

For more information and/or assistance, please contact Donna Catherwood, catherwood@hhsc.ca

Important Dates

Submission deadline: May 1

Important Forms

CHPA Application Form
CHPA Guidlines for Application

Submit to: researchnetwork@hhsc.ca

Past Recipients 

2016 CHP Award Recipients

Clinical Health Professional Travel Awards (TA)

New Open Call Model to provide more flexibility to align with external conference deadlines, as well as clinical workload.

The Clinical Health Professionals Research Travel Award provides support for eligible non-physician Health Professionals to present their work at a scientific meeting of relevance to their practice/research. Up to six awards on a competitive basis will be given within a calendar year, and are each valued up to a maximum of $2,500 for a national conference or $3,500 for international (funds in Canadian dollars);

  • An abstract must be accepted for a national or international conference (not local or regional); and
  • applicants must be the first author on the abstract.

This funding program is led by Dr. Sandra Carroll, Director, Clinical Health Professional Research, carroll@mcmaster.ca. Interested candidates are recommended to contact Dr. Carroll or Daniela Bianco biancdan@hhsc.ca in advance of their submission.

For more information and/or assistance, please contact Donna Catherwood, catherwood@hhsc.ca

Open Call Model

Submission of Travel Awards application is required three months in advance of attending conference

Important Forms

TA Application Form
TA Expense Reimbursement Policy
TA Guidelines for Applications

Submit to: travelawards@hhsc.ca

Past Recipients 

2018 Travel Award Recipients 

Research Strategic Initiatives Request for Applications (RFA)

PLEASE NOTE: THERE WILL BE NO 2020 COMPETITION OFFERED

The Research Strategic Initiatives RFA Program is a competitive call to fund new research areas of high strategic priority to support emerging areas/teams with high potential for research success. This strategy will expand the existing base of research at Hamilton Health Sciences with the goal that a few new areas of research will achieve national or international stature within the next 5 to 10 years.

For more information contact Donna Catherwood, catherwood@hhsc.ca

Important Forms

RFA – Guidelines for Application
RFA Budget Template

Submit to: researchnetwork@hhsc.ca

Past Recipients 

2018 RFA Award Recipients

Canada Research Continuity Emergency Fund

CRCEF Program Overview and Objectives

As part of its COVID-19 Economic Response Plan, the Government of Canada recently introduced the Canada Research Continuity Emergency Fund (CRCEF) program.

The objectives of the program are to:

  • provide wage support to universities and health research institutions (including Hamilton Health Sciences) to help them to retain research-related personnel during the course of the COVID-19 pandemic; and
  • support extraordinary incremental costs associated with maintaining essential research-related commitments during the COVID-19 pandemic, and then ramping-up to full research activities as physical distancing measures are eased and research activities can resume.

Funding Overview

The CRCEF program includes three funding stages.

Stages 1 and 2 provide wage support for research personnel (i.e. undergraduate or graduate students, postdoctoral fellows, and other personnel associated with research projects) who are, or were:

  • employed by universities or health research institutions (including Hamilton Health Sciences) for some period of time between March 15th and August 29th, 2020;
  • working for faculty members conducting research, or in scientific and engineering facilities/laboratories supporting broad research objectives;
  • unable to do all or some of the work for which they were hired as a consequence COVID-19;
  • paid in part or in whole from eligible non-governmental sources, or were supposed to be paid from eligible non-governmental sources but were paid less than planned or laid off as a result of COVID-19; and
  • not claiming other wage support (e.g. Canada Emergency Response Benefit [CERB]).

Stage 3 of the CRCEF program provides support for direct costs incurred between March 15th and November 15th, 2020, associated with maintenance and ramp-up of research activities, such as:

  • animal and specimen care through the crisis period;
  • maintenance of equipment, software, cohorts, datasets, including warranties, licenses and service contracts;
  • technological equipment for remote access to maintain assets;
  • safety equipment for personnel dedicated to maintenance;
  • re-organizing the research environment and activities;
  • additional costs to bring the research back to its pre-pandemic level, including experiments or related to the restart of collections and datasets (e.g., population-based, environmental);
  • re-scheduling and restarting human and clinical trials;
  • exceptional costs to access special facilities, platforms and resources, knowledge transfer meetings and workshops;
  • restarting, reassembling and safety checks of equipment and facilities;
  • reacquiring lost and donated laboratory and field supplies and equipment, reagents, perishable materials, laboratory animal and other living specimens; and
  • personal protective equipment and related items for research personnel.

To access CRCEF funding McMaster must submit an application to each stage of the program demonstrating need for the requested funding. The applications are submitted by McMaster University on behalf of the University and its affiliated health research institutions – Hamilton Health Sciences Corporation (HHSC) and St. Joseph’s Healthcare Hamilton (SJHH).

Funding Stage 1

The CRCEF program awarded Stage 1 funding to universities and their affiliated health research institutions (including us at Hamilton Health Sciences) on the basis of a formula that was applied to each institution’s annual average over three years (2015-16 to 2017-18) of the total of research income from all non-governmental sources as indicated in the Canadian Association of University Business Officers (CAUBO) research income reports.

The Stage 1 funds awarded to McMaster University, and their affiliated health research institutions, HHSC and SJHH, were allocated among the three institutions in accordance with the share of the awarded funds earned by each institution. The share of allocation earned was determined by each institution’s share of the average over three years (2015-16 to 2017-18) of the total of research income from all non-governmental sources outlined in the CAUBO research income report.

Based on an assessment of the data available from our respective institutional systems and information obtained directly from Researchers, HHSC and SJHH have determined that their shares of the awarded CRCEF Stage 1 funds are sufficient to address the need for eligible wage support at their institutions.

Funding Stage 2

A similar assessment of institutional systems data and information obtained from researchers regarding eligible costs was conducted by McMaster University. Based on that assessment the University has determined that they will not apply for additional funding for wage from Stage 2 of the CRCEF program.

Funding Stage 3

For Stage 3, an initial maximum payable allocation per applicant will be established based on the applicant’s proportionate share of total sponsored research income (including governmental research income).

This allocation will be based on the publicly available FIUC data from CAUBO and the supplemental data provided by universities and non-affiliated health research institutions not included in the CAUBO dataset. Applicants must justify need for the funds based on actual costs incurred. If some applicants do not establish need or do not request Stage 3 funding up to their maximum allocation, funds will be reallocated on a prorated basis to those applicants demonstrating need in excess of their maximum Stage 3 allocation. For Stage 3, the maximum payable allocation will be calculated according to the following formula. For each applicant, the distribution will be prorated and based on:

  • the CAUBO total research income data, or data on total research income provided by universities and non-affiliated health research institutions not included in the CAUBO dataset; and
  • the annual average over three years (2015-16 to 2017-18) for the total research income from all sources.”

Strategy for Equity, Diversity and Inclusive Decision-Making

Decisions regarding the allocation of CRCEF funds within Hamilton Health Sciences will be made by the Executive Committee on Research (ECOR).  ECOR is chaired by the Vice-President Research, and includes individuals who represent historically under-represented groups.  All ECOR members have received training in unconscious bias.

Current representation of voting members include:

Chair: VP, Research & Chief Innovation Officer
Executive VP , Academic & Chief Medical Executive
Executive VP, Corporate Affairs & Chief Financial Officer
Executive Director, Population Health Research Institute
Deputy Director, Population Health Research Institute
Executive Director, Thrombosis & Atherosclerosis Research Institute
Director, Escarpment Cancer Research Institute
Director, Offord Centre for Child Studies
Director, Geriatrics Education Research Aging Sciences
Director, Clinical Health Professionals Research
Associate Dean of Research, Faculty of Health Sciences at McMaster University

Ad Hoc Member/HHS CRCEF Representative:  Anthony Scandinavo, Director of Research Finance

HHS’ Executive Committee on Research is committed to managing the CRCEF funds in a manner that aligns with the principles of equity, diversity and inclusion. The decisions made by ECOR regarding allocation of CRCEF funds awarded to Hamilton Health Sciences are consistent with HHS’ commitment to value and respect the richness of diversity of the communities we serve, and dedicated to cultivating a welcoming, inclusive and safe environment free from discrimination and oppression for everyone who enters through our doors.

At HHS, we actively strive to create an equitable environment where people’s diverse identities and perspectives are valued and included. We strive to create an environment where all staff feel dignified, engaged, and empowered to deliver on HHS’ mission of Best Care for All. HHS recognizes its people are best positioned to do this by increasing their skills, confidence, and capabilities through a range of human rights and inclusion training and programs, events, and projects.

Specifically, our Human Rights and Inclusion initiatives include various training and programs that are specifically designed to educate our workforce on equitable and social engagement with the diverse communities we work with and provide care for at HHS:

  • Two-Spirit & LGBTQIA+ Positive Space Training
  • Ally in Action Training
  • Compassionate Cross Cultural Communication Training
  • Intersectional Anti-Racism: Anti-Oppression Analysis Training
  • Ethics and Diversity Grand Rounds
  • On-demand training related to harassment, workplace violence, and other human rights-related issues.

For more details on Human Rights and Inclusion initiatives, please visit the Office of Human Rights and Inclusion section on this page (click).

To minimize the impact of implicit biases and systemic barriers, while acknowledging inequities that contribute to differing experiences of COVID-19, the following commitments will guide ECOR’s management of the CRCEF funds:

  • All HHS Researchers, regardless of discipline or area of focus, have the opportunity and have been encouraged to identify costs that are eligible for CRCEF support;
  • All eligible requests for CRCEF support will receive the same consideration; and
  • The process whereby costs eligible for CRCEF funding are identified will be simple, flexible, and account for the fact that the circumstances of some HHS Researchers (such as other demands and/or commitments, health issues or technological limitations) may impact their ability to participate in the process.

In accordance with these directives, upon release of the CRCEF program guidelines, to ensure that all researchers were aware of the CRCEF program and had the opportunity to request support, an announcement was issued to all HHS Researchers, as well as the larger research community, advising them of the CRCEF funding opportunity, and encouraging them to identify and request support for eligible costs.

A process was created to provide HHS Researchers an opportunity to identify their need for CRCEF funding and assign delegates to provide information on their behalf, should they choose to do so. Information about who to contact for assistance was shared with all Researchers, over email, and at regular HHS Research Townhalls. Moreover, HHS researchers were directed to the Canada Research Continuity Emergency Fund (CRCEF) website to gain an understanding of the details of the funding program.  Our Research Finance team also did a full HHS Research Enterprise scan to assess the eligible wage support needs of HHS’ research community.

Hamilton Health Sciences’ Executive Committee on Research has decided that, if all of the funding requested is awarded, it will be allocated within HHS such that all eligible costs will receive the maximum amount allowed by the CRCEF program guidelines. If HHS does not have sufficient CRCEF funding to fully fund all identified needs, then the available funding will be allocated such that each Researcher will receive the same percentage of the amount of funding requested.

Contact Information

The following Hamilton Health Sciences representative is responsible for ensuring the CRCEF program’s requirements are satisfied, and can be contacted should there be any questions or concerns regarding management of CRCEF funds at Hamilton Health Sciences:

Anthony Scandinavo, Director, Research Finance
Hamilton Health Sciences Corporation
Email: scandinavo@hhsc.ca